Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.7 |
mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |